|
KCTD6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.73109999668242E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.63657976059994E-12 |
| Stage1-vs-Stage2 |
7.026200E-01 |
| Stage1-vs-Stage3 |
4.752200E-04 |
| Stage1-vs-Stage4 |
4.981100E-03 |
| Stage2-vs-Stage3 |
7.962900E-03 |
| Stage2-vs-Stage4 |
1.501940E-02 |
| Stage3-vs-Stage4 |
8.944000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.12030000223962E-08 |
| Normal-vs-Asian |
7.60560000534483E-08 |
| Caucasian-vs-AfricanAmerican |
4.587000E-01 |
| Caucasian-vs-Asian |
3.949700E-02 |
| AfricanAmerican-vs-Asian |
7.814100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.6621374255883E-15 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
5.218600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
1.86017999999066E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.353800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.252560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.339200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.118600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.932600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.430000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.0228000002499E-07 |
| Classical-VS-Follicular |
7.378300E-02 |
| Classical-VS-Other |
4.434000E-01 |
| Classical-VS-Normal |
6.13153972039981E-12 |
| Tall-VS-Follicular |
4.34259994630537E-09 |
| Tall-VS-Other |
6.146100E-02 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
8.616000E-01 |
| Follicular-VS-Normal |
2.7959001780431E-10 |
| Other-VS-Normal |
1.504400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.55111512312578E-16 |
| Normal-vs-N1 |
7.02893299120433E-12 |
| N0-vs-N1 |
1.674210E-01 |
|
|
